← Eichor
Study identifier: NCT06158529 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

High-frequency SCS Versus SCS in the Treatment of Diabetic Peripheral Neuropathic Pain

Condition: Painful Diabetic Peripheral Neuropathy  ·  Sponsor: Fan BiFa

PhaseNA
Planned participants1
Who can joinAll sexes, 18 Years to 80 Years
Healthy volunteersNo

About this study

Application of High-Frequency Spinal Cord Stimulation (HF-SCS) in the Treatment of Painful Diabetic Peripheral Neuropathy (PDPN): A multicenter, randomized controlled study comparing its clinical efficacy with traditional spinal cord stimulation for PDPN. The study aims to observe the impact of HF-SCS on the neurological function and microcirculation of PDPN patients, elucidating the correlation between the underlying diabetes and the efficacy of HF-SCS therapy on PDPN. The goal is to enhance the treatment standards for PDPN, improve the quality of life for this population, and overall treatment outcomes. Simultaneously, the study aims to contribute evidence-based medicine for the mechanistic exploration of PDPN.

This description comes directly from the study's public registry record.

Talk to the study team

BiFa Fan, master  ·  18811358829  ·  Lichen1616@outlook.com

Always discuss trial participation with your own doctor first.

Locations (1)

China-Japan Friendship HospitalBeijing, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06158529